Prescribing of Low versus High-Cost Part B Drugs in Medicare Advantage and Traditional Medicare.

Our findings show MA enrollees were more likely than TM enrollees to receive low-cost Part B drugs in four clinical scenarios where multiple similarly or equally effective treatment options exist. This article is protected by copyright. All rights reserved.